SGCB and cardiovascular disorder: Thus, as highlighted by our study, the sGC activator Bay 60 is more likely to be advantageous in settings of oxidative stress, such as those observed in cardiovascular diseases and diabetes, as a consequence of targeting heme-free sGC.